Expert psychiatric care led by a quadruple board-certified psychiatrist with over 20 years of clinical and academic experience.
The Comprehensive Psychiatric Evaluation (CPE) is the most thorough diagnostic service offered at Cognitive Works. At approximately 90 minutes, it is deliberately longer and more detailed than a standard psychiatric appointment — and it needs to be. Most psychiatric visits in clinical practice run about 60 minutes and are designed around focused, practical goals: reviewing medications, adjusting dosages, and managing ongoing treatment. That is the role of a Medication Management Consultation, and it serves that purpose well. But a CPE is a fundamentally different encounter, built for a fundamentally different purpose.
A Comprehensive Psychiatric Evaluation is designed for patients who need — or want — a complete picture. Rather than focusing on a single presenting concern, the CPE systematically screens across all major categories of mental illness as defined in the DSM-5, published by the American Psychiatric Association. This extended interview covers mood disorders, anxiety disorders, psychotic disorders, substance use, personality patterns, trauma history, cognitive functioning, and more — ensuring that nothing is overlooked and that co-occurring conditions, which are common in psychiatry, are identified rather than missed.
This level of evaluation is not part of a routine psychiatric visit. It must be specifically requested, and for good reason: it requires dedicated time, a structured clinical methodology, and the kind of broad diagnostic expertise that comes from advanced training across multiple psychiatric subspecialties. The result is not just a diagnosis — it is a detailed clinical report with a comprehensive screening summary and a set of individualized treatment and management recommendations tailored to your specific situation.
Whether you are seeking clarity on a new or uncertain diagnosis, entering psychiatric care for the first time, or looking for a thorough reassessment of your mental health after years of treatment, the CPE provides the depth and precision that a standard appointment simply cannot offer.
The Medication Management Consultation (MMC) is the most common type of psychiatric appointment and represents the standard format for ongoing psychiatric care. Unlike the Comprehensive Psychiatric Evaluation, which is an extended diagnostic deep-dive, the MMC is designed to be focused, practical, and efficient — centered on the real-world management of your psychiatric medications.
The process begins with an initial intake appointment of approximately 60 minutes — the standard length for a psychiatric interview. During this first visit, your psychiatrist will review your psychiatric history, current medications, medical conditions, and treatment goals. The emphasis is on understanding your medication landscape: what has been tried, what has worked, what has not, and what adjustments may be needed going forward. While your diagnosis is reviewed during intake, the primary focus of the MMC is treatment management rather than diagnostic re-evaluation.
Following the initial visit, a first follow-up is generally required within one month to assess how you are responding to any new medications or adjustments. From there, the frequency of ongoing visits depends on the nature of your prescriptions and the stability of your condition.
Controlled substance prescriptions (such as stimulants, benzodiazepines, or certain sleep medications) require a minimum of quarterly visits — at least once every three months — as part of responsible prescribing and regulatory compliance. Non-controlled medications in stable patients typically require at least biannual visits — a minimum of twice per year. Any change in medication or dosage adjustment will generally require a follow-up within one month to evaluate efficacy and tolerability.
It is also important to understand that continuity of care is a cornerstone of safe prescribing. If you are transferring from another provider, Cognitive Works may need to contact your previous prescribing physician or obtain prior medical records before continuing existing prescriptions. This is not a bureaucratic formality — it is a clinical safeguard that ensures your treatment history is fully understood and that your ongoing care is built on a complete and accurate foundation.
Pharmacogenomics (PGx) applies the science of human genetics to medication selection. Rather than relying on trial and error, PGx testing allows your psychiatrist to make prescribing decisions informed by your unique genetic profile — turning educated guessing into precision medicine.
Genetic variations in liver enzymes (CYP2D6, CYP2C19, CYP3A4, and others) determine whether you metabolize a medication normally, too quickly, or too slowly. A "poor metabolizer" may experience amplified side effects, while an "ultra-rapid metabolizer" may clear a drug before it reaches therapeutic levels. In psychiatry — where antidepressants, antipsychotics, and other medications are among the most affected by genetic variability — identifying these differences can fundamentally change the trajectory of treatment.
During your consultation, your psychiatrist determines that pharmacogenomic testing is appropriate for your care and places the order online through a certified laboratory.
A collection kit is mailed directly to your home. The packet includes everything you need — a simple cheek swab, clear instructions, and prepaid return packaging.
You complete a painless cheek swab at home — no blood draw required — and mail the sample back to the laboratory using the prepaid return packaging included in your kit.
Results are sent directly to your psychiatrist, typically within one to two weeks. The Cognitive Works clinical team reviews the findings in the context of your full psychiatric history, translating genetic data into actionable prescribing recommendations.
Studies show fewer than half of patients respond adequately to their first psychiatric medication. PGx testing enhances clinical judgment by explaining why previous medications failed, identifying which drugs are most likely to work, flagging elevated risk of adverse reactions, and guiding dosing decisions — all before a prescription is written.
Multiple medication failures — You have tried two or more psychiatric medications without adequate response or with intolerable side effects
Unusual side effects — You experience side effects at doses that are well tolerated by most patients, suggesting altered drug metabolism
Starting new treatment — You are beginning psychiatric medication for the first time and want to minimize the trial-and-error process from the outset
Complex medication regimens — You are on multiple medications and want to identify potential gene-drug or drug-drug interactions
Family history concerns — Close relatives have experienced serious adverse drug reactions or unusual medication responses
Treatment-resistant diagnoses — Your condition has been labeled "treatment-resistant" and you want to determine whether genetic factors may explain prior treatment failures
Your appointment includes a full psychiatric assessment followed by test ordering through a certified laboratory. The kit ships to your home, you complete a simple cheek swab, and mail it back. Results arrive within one to two weeks and are reviewed in the context of your full clinical history. This is a one-time test with lifetime value — your pharmacogenes never change.
Insurance Coverage: Most major health insurance plans — including Medicare — provide coverage for pharmacogenomic testing, particularly when there is a documented history of treatment failure or adverse drug reactions. Our office will work with you to verify coverage before testing is ordered. The necessity for any follow-up appointments will be assessed after the initial consultation and once genetic results are available.
Psychiatry stands apart from most medical specialties in one important way: there is no blood test, imaging study, or laboratory value that can definitively confirm a psychiatric diagnosis. Every diagnosis rests on the clinician's ability to synthesize a patient's history, presentation, and symptom patterns — and that process is deeply influenced by the clinician's training, theoretical orientation, and depth of experience. It is not uncommon for two well-meaning psychiatrists to arrive at different conclusions about the same patient, and even small diagnostic differences can lead to fundamentally different treatment paths.
This is precisely why a psychiatric second opinion is not a luxury — it is a safeguard. If you have been living with a diagnosis that does not fully explain your symptoms, if your treatment has plateaued despite multiple medication trials, or if you simply want the reassurance that your current plan is on the right track, an independent review by a highly qualified psychiatrist can provide the clarity you need to move forward with confidence.
The value of a second opinion, however, depends entirely on who is providing it. Psychiatry encompasses a wide range of subspecialties and evolving schools of thought, and complex cases often sit at the intersection of several of them — mood disorders complicated by substance use, psychiatric symptoms driven by underlying medical conditions, medication resistance that calls for pharmacogenomic insight, or diagnostic ambiguity between conditions that can look remarkably similar on the surface. Evaluating these cases requires not just general psychiatric training, but the kind of multi-disciplinary expertise and academic rigor that comes from years of advanced fellowship training and faculty-level practice at leading institutions.
Addiction Psychiatry is a specialized branch of psychiatry focusing on the evaluation, diagnosis, and treatment of individuals suffering from addiction. This subspecialty necessitates a rigorous training program, including a four-year residency in psychiatry followed by an additional year dedicated solely to mastering addiction psychiatry.
In academic settings, the responsibility of conducting diagnostic assessments typically falls on psychiatrists who have achieved board certification in Addiction Psychiatry. Similarly, at Cognitive Works, the Addiction Diagnostic Assessments are meticulously carried out by a psychiatrist with board certification in this particular field, ensuring a high standard of care for patients grappling with addiction issues.
Our comprehensive addiction assessment is designed to address a wide range of substances and behaviors that can lead to addiction. Chemical dependencies can have profound effects on an individual's physical and mental health, relationships, and overall quality of life.
In addition to substance-related addictions, we also recognize the growing concern surrounding behavioral addictions. These non-substance-related disorders can be equally debilitating and encompass a range of activities.